A Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Participants
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
This is a Phase I, open-label, randomized, four-treatment period, four-sequence, single-dose,
crossover pharmacokinetic study to determine the bioequivalence of pirfenidone after
administration of tablet and capsule dosage forms under both fed and fasted conditions.